Skip to search formSkip to main contentSkip to account menu

PCA 4230

Known as: 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,4,6-trimethyl-, ethyl 2-(3-oxo-1,2-benzisothiazol-2(3H)-yl)ethyl ester, S,S-dioxide, PCA-4230 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Dihydropyridines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Inhibition of the cyclin D1/E2F pathway by PCA‐4230, a potent repressor of cellular proliferation
Tight control of cellular growth is essential to ensure normal tissue patterning and prevent pathological responses. Excessive… 
1997
1997
Antiproliferative effects of PCA‐4230, a new antithrombotic drug, in vascular smooth muscle cells
In the present study we examined the effects of PCA‐4230, a novel antithrombotic agent, on the growth of cultured A10 vascular… 
1997
1997
Antiproliferative e ects of PCA-4230 , a new antithrombotic drug , in vascular smooth muscle cells
1 In the present study we examined the e€ects of PCA-4230, a novel antithrombotic agent, on the growth of cultured A10 vascular… 
1997
1997
Involvement of cyclic GMP in the mode of action of a new antithrombotic agent PCA-4230; inhibition of the platelet cyclic GMP dependent phosphodiesterase.
1994
1994
Dissociation between secretion and protein phosphorylation in agonist-stimulated platelets; action of PCA-4230, a new antithrombotic drug.
1993
1993
New 4-alkyl-1,4-dihydropyridines: evaluation of photostability and phototoxic potential.
1993
1993
PAF and thrombin actions in platelets are selectively affected by a new 1,4-dihydropyridine derivative.
In the present study we described the effects of a new 1,4-dihydropyridine derivative with antithrombotic activity on… 
1992
1992
Interaction of platelets with subendothelium in rats treated with PCA-4230, a new antithrombotic agent. Effect of PCA-4230 on experimental thrombosis.
The effects of a new antithrombotic compound, PCA-4230, versus ticlopidine were investigated using an experimental thrombosis and… 
1992
1992
Selective inhibition of ADP-induced calcium entry in rat platelets by PCA-4230 (trombodipine)
1987
1987
PROTECTIVE EFFECT OF A NEW SYNTHETIC COMPOUND: PCA-4230, ON SEVERAL In vivo THROMBOSIS MODELS.
PCA-4230 is a new anti-thrombotic compound which inhibits pla. telet aggregation In vltn.0 and ex. vivo in several species… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)